Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Hydrogel-based Drug Delivery System Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Hydrogel-based Drug Delivery System Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Hydrogel-based Drug Delivery System Market: Polymer Origin Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Hydrogel-based Drug Delivery System Market: Polymer Origin Movement Analysis, 2023 & 2030 (USD Million)
4.3. Natural
4.3.1. Natural Polymer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Synthetic
4.4.1. Synthetic Polymer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Hybrid
4.5.1. Hybrid Polymer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Hydrogel-based Drug Delivery System Market: Delivery Route Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Hydrogel-based Drug Delivery System Market: Delivery Route Movement Analysis, 2023 & 2030 (USD Million)
5.3. Subcutaneous
5.3.1. Subcutaneous delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Ocular
5.4.1. Ocular delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Oral Cavity
5.5.1. Oral Cavity delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Topical
5.6.1. Topical delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Other delivery routes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Hydrogel-based Drug Delivery System Market: Regional Estimates & Trend Analysis
6.1. Hydrogel-based Drug Delivery System Market Share, By Region, 2023 & 2030, USD Billion
6.2. North America
6.2.1. North America Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. UK Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Denmark Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Sweden Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Norway Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. China
6.4.2.1. China Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Japan
6.4.3.1. Japan Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. South Korea
6.4.5.1. South Korea Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Saudi Arabia
6.6.2.1. Saudi Arabia Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. UAE
6.6.3.1. UAE Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. Kuwait
6.6.4.1. Kuwait Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. South Africa
6.6.5.1. South Africa Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. GE HealthCare
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Siemens Healthineers AG
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Medtronic
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Aramark
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Koninklijke Philips N.V.
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. B. Braun SE
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. AlphaSource Group
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Althea Group
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives